US Patent

US7968559 — Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds

Method of Use · Assigned to Lexicon Pharmaceuticals Inc · Expires 2027-12-11 · 2y remaining

Vulnerability score 75/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects methods of using compounds, including telotristat etiprate, to treat, prevent, and/or manage diseases and disorders.

USPTO Abstract

Compounds of formula I are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and/or manage diseases and disorders:

Drugs covered by this patent

telotristat-etiprate (TELOTRISTAT ETIPRATE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-1979`	—	telotristat-etiprate

Patent Metadata

Patent number: US7968559
Jurisdiction: US
Classification: Method of Use
Expires: 2027-12-11
Drug substance claim: No
Drug product claim: No
Assignee: Lexicon Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.